FDA NDC Directory · JSON-LD · Markdown
NDC 63323-327 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
| Generic name | NAFCILLIN SODIUM |
|---|---|
| Labeler / Manufacturer | Fresenius Kabi USA, LLC |
| Marketing category | Abbreviated NDA (generic) · App ANDA090002 |
| Dosage form / route | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAMUSCULAR INTRAVENOUS |
| Active ingredients | NAFCILLIN SODIUM (1 g/4mL) |
| Marketing started | 20110630 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).